X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (63) 63
male (50) 50
female (48) 48
middle aged (46) 46
aged (43) 43
cardiac & cardiovascular systems (31) 31
risk factors (29) 29
treatment outcome (26) 26
medicin och hälsovetenskap (24) 24
medical and health sciences (23) 23
myocardial infarction (22) 22
stroke (20) 20
abridged index medicus (19) 19
double-blind method (19) 19
drug therapy (19) 19
mortality (18) 18
prevention (18) 18
risk (16) 16
atrial fibrillation (15) 15
drug therapy, combination (15) 15
clopidogrel (14) 14
coronary heart disease (14) 14
cardiovascular diseases (13) 13
care and treatment (13) 13
hypertension (13) 13
myocardial-infarction (13) 13
acute coronary syndrome (12) 12
heart attacks (12) 12
medicine, general & internal (12) 12
warfarin (12) 12
adult (11) 11
cardiovascular disease (11) 11
clinical medicine (11) 11
kardiologi (11) 11
klinisk medicin (11) 11
peripheral vascular disease (11) 11
platelet aggregation inhibitors - therapeutic use (11) 11
ticlopidine - analogs & derivatives (11) 11
acute coronary syndromes (10) 10
aspirin (10) 10
cardiac and cardiovascular systems (10) 10
cardiovascular diseases - prevention & control (10) 10
cardiovascular (9) 9
follow-up studies (9) 9
health aspects (9) 9
hemorrhage - chemically induced (9) 9
platelet aggregation inhibitors - adverse effects (9) 9
therapy (9) 9
ticlopidine - therapeutic use (9) 9
acute coronary syndrome - drug therapy (8) 8
anticoagulants (8) 8
apixaban (8) 8
atrial fibrillation - drug therapy (8) 8
bleeding (8) 8
blood pressure (8) 8
coronary artery disease (8) 8
electrocardiography (8) 8
heart diseases (8) 8
incidence (8) 8
metaanalysis (8) 8
patient outcomes (8) 8
stroke - prevention & control (8) 8
angina pectoris (7) 7
anticoagulants - therapeutic use (7) 7
clinical trials (7) 7
diabetes mellitus (7) 7
events (7) 7
ischemia (7) 7
unstable angina (7) 7
usage (7) 7
acute myocardial-infarction (6) 6
antihypertensive agents - therapeutic use (6) 6
benzimidazoles - therapeutic use (6) 6
cerebral infarction (6) 6
cholesterol, ldl - blood (6) 6
dabigatran (6) 6
global health (6) 6
health risk assessment (6) 6
hypertension - complications (6) 6
internal medicine (6) 6
management (6) 6
myocardial infarction - epidemiology (6) 6
myocardial infarction - mortality (6) 6
percutaneous coronary intervention (6) 6
proportional hazards models (6) 6
research (6) 6
risk assessment (6) 6
ticagrelor (6) 6
time factors (6) 6
verapamil (6) 6
administration, oral (5) 5
angina (5) 5
anticoagulants - administration & dosage (5) 5
anticoagulants - adverse effects (5) 5
anticoagulation (5) 5
atenolol (5) 5
benzimidazoles - administration & dosage (5) 5
cardiovascular diseases - epidemiology (5) 5
coronary angiography (5) 5
coronary artery bypass (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2010, Volume 375, Issue 9711, pp. 283 - 293
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2008, Volume 372, Issue 9638, pp. 547 - 553
Summary Background Angiotensin receptor blockers (ARB) and angiotensin converting enzyme (ACE) inhibitors are known to reduce proteinuria. Their combination... 
Internal Medicine | COOPERATE | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | RENIN-ANGIOTENSIN SYSTEM | DISEASE | PROTEINURIA | CONVERTING ENZYME-INHIBITORS | COMBINATION | NEPHROPATHY | II RECEPTOR BLOCKERS | PROGRESSION | Benzoates - adverse effects | Angiotensin II Type 1 Receptor Blockers - adverse effects | Benzoates - therapeutic use | Follow-Up Studies | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Ramipril - administration & dosage | Proteinuria - chemically induced | Cardiovascular Diseases - complications | Glomerular Filtration Rate - drug effects | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Benzimidazoles - administration & dosage | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Ramipril - therapeutic use | Benzimidazoles - adverse effects | Drug Therapy, Combination | Ramipril - adverse effects | Angiotensin II Type 1 Receptor Blockers - administration & dosage | Benzimidazoles - therapeutic use | Kidney - drug effects | Double-Blind Method | Diabetes Mellitus - drug therapy | Proteinuria - metabolism | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Creatinine - urine | Benzoates - administration & dosage | Creatinine - blood | Aged | Urine | Drugs | Studies | Kidneys | Disease | Clinical trials | Risk | ACE inhibitors | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2008, Volume 371, Issue 9621, pp. 1353 - 1363
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2016, Volume 374, Issue 21, pp. 2021 - 2031
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2016, Volume 374, Issue 21, pp. 2009 - 2020
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2016, Volume 374, Issue 21, pp. 2032 - 2043
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2011, Volume 365, Issue 8, pp. 699 - 708
Journal Article